In the BioHarmony Drug Report Database

"Preview" Icon

Uracil mustard

Uracil Mustard (uracil mustard) is a small molecule pharmaceutical. Uracil mustard was first approved as Uracil Mustard on 1982-01-01. It is used to treat b-cell chronic lymphocytic leukemia, bcr-abl positive chronic myelogenous leukemia, mycosis fungoides, ovarian neoplasms, and polycythemia vera amongst others in the USA.

 

Trade Name

 

Uracil Mustard
 

Common Name

 

uracil mustard
 

ChEMBL ID

 

CHEMBL1488
 

Indication

 

b-cell chronic lymphocytic leukemia, bcr-abl positive chronic myelogenous leukemia, mycosis fungoides, ovarian neoplasms, polycythemia vera, thrombocytosis
 

Drug Class

 

Uracil type antineoplastics

Image (chem structure or protein)

Uracil mustard structure rendering